iData Research: Global Cardiac Rhythm Management market to hit $36B by 2032. Leadless pacing and pulsed field ablation lead the industry.
Cash and cash equivalents stood at $80.7 million as of December 31, 2025, which management believes is sufficient to fund operations through major 2026 inflection points. Non-GAAP expenses increased ...
Pulse BioSciences’ CTO knows what it takes to create successful medtech and sometimes, it takes partnering with the competition.
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2025 Earnings Call Transcript February 20, 2026 Operator: Ladies and gentlemen, thank you for standing by. My name is Colby, and I will be your conference ...
23h
Pulse Biosciences targets CE Mark submission in 2026 as nPulse platform advances clinical milestones
Q4 2025 earnings call: nsPFA clinical/regulatory timeline, Vybrance rollout, revenue trends, cash burn & outlook—read now.
Senior health insurance in India has expanded significantly in recent years, with wider coverage for pre-existing conditions and more flexible underwriting for older applicants. On paper, this makes ...
During a cardiac arrest, every second counts. Kaleida Health announced earlier this week that Bradford Regional Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results